lonza manufacture yes, but they are not questioning lonza’s ability... they are questioning MSB’s methodology in determining how to measure the cells potency.
lonza can’t help with that IMO
FDA ODAC Meeting Material discussion analysis, page-317
-
- There are more pages in this discussion • 175 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
95.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.084B | |||
| Open | High | Low | Value | Volume |
| 94.5¢ | 95.0¢ | 93.5¢ | $288.2K | 305.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 14775 | 95.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 95.5¢ | 31129 | 4 |
View Market Depth
| Last trade - 10.15am 12/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |